DM1-SMCC – 5 mg

Brand:
Cayman
CAS:
1228105-51-8
Storage:
-20
UN-No:
Non-Hazardous - /

N2′-deacetyl-N2′-[3-[[1-[[4-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]cyclohexyl]methyl]-2,5-dioxo-3-pyrrolidinyl]thio]-1-oxopropyl]-maytansine DM1-SMCC is a cleavable linker-based antibody-drug conjugate (ADC) containing the maytansinoid DM1 (mertansine; Item No. 22483) and the crosslinker SMCC.{35225,35224} ADCs target specific cell populations to induce a selective response, such as cell death in cancer cells. DM1-SMCC conjugated to an anti-CD70 antibody has been used to study the transport of the ADC catabolites into the cell cytoplasm of 786-0 renal cell carcinoma cells.  

 

Available on backorder

SKU: 23926 - 5 mg Category:

Description

An antibody-drug conjugate containing the maytansinoid DM1 and the crosslinker SMCC


Formal name: N2′-deacetyl-N2′-[3-[[1-[[4-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]cyclohexyl]methyl]-2,5-dioxo-3-pyrrolidinyl]thio]-1-oxopropyl]-maytansine

Synonyms:  SMCC-DM1

Molecular weight: 1,072.60

CAS: 1228105-51-8

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals||Research Area|Cancer|Cell Death